GSK3B and type 2 diabetes mellitus: We have also reported that the platelet GSK‐3β activity is increased in T2DM with MCI (T2DM‐MCI) patients compared to T2DM without MCI (T2DM‐nMCI) (Z. P. Xu et al., 2016).